Shire to Sell Oncology Unit for $2.4 Billion to Servier
Shire PLC has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Japan’s Takeda Pharmaceutical Co. from launching a takeover of the London-listed company.
Takeda said in March it was considering a bid for Shire and identified its oncology business as one of the main reasons for its interest. A pursuit of Shire would be one of the biggest attempts by a Japanese company to buy a Western rival.
Source link: https://www.wsj.com/articles/shire-to-sell-oncology-unit-for-2-4-billion-to-servier-1523871333?mod=pls_whats_news_us_business_f